Skip to main content

Table 2 Lipid Mean % Change (+/- SE) from Baseline at Week 48 – As Treated Subjects

From: Atazanavir is safe and efficacious in HBV and HCV co-infected patients: results of AI424138 (CASTLE)

 

ATV/r N = 60

LPV/r N= 51

Total Cholesterol (TC)

12 (9.4, 15.3)

23 (20.1, 26.4)

HDL

28 (24.2, 32.4)

42 (32.3, 53.1)

Non-HDL

7 (3.1, 10.9)

17 (14.2, 20.9)

LDL

12 (6.4, 16.9)

21 (14.6, 27.8)

Triglycerides (TG)

18 (9.8, 27.1)

45 (33.2, 58.2)